Pulmonx EBITDA 2019-2025 | LUNG
Pulmonx ebitda from 2019 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Pulmonx Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-58 |
| 2023 | $-61 |
| 2022 | $-57 |
| 2021 | $-46 |
| 2020 | $-31 |
| 2019 | $-18 |
| 2018 | $-15 |
| Pulmonx Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-14 |
| 2024-12-31 | $-13 |
| 2024-09-30 | $-14 |
| 2024-06-30 | $-16 |
| 2024-03-31 | $-14 |
| 2023-12-31 | $-14 |
| 2023-09-30 | $-15 |
| 2023-06-30 | $-16 |
| 2023-03-31 | $-16 |
| 2022-12-31 | $-14 |
| 2022-09-30 | $-14 |
| 2022-06-30 | $-14 |
| 2022-03-31 | $-15 |
| 2021-12-31 | $-12 |
| 2021-09-30 | $-10 |
| 2021-06-30 | $-12 |
| 2021-03-31 | $-12 |
| 2020-12-31 | $-9 |
| 2020-09-30 | $-5 |
| 2020-06-30 | $-11 |
| 2020-03-31 | $-6 |
| 2019-12-31 | |
| 2019-09-30 | $-4 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.129B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.399B | 58.01 |
| Hims & Hers Health (HIMS) | United States | $11.729B | 121.86 |
| Tempus AI (TEM) | United States | $9.423B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.541B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.078B | 63.71 |
| Privia Health (PRVA) | United States | $2.749B | 187.92 |
| Enovis (ENOV) | United States | $1.831B | 10.21 |
| Clover Health Investments (CLOV) | United States | $1.593B | 0.00 |
| Schrodinger (SDGR) | United States | $1.573B | 0.00 |
| Phreesia (PHR) | United States | $1.454B | 0.00 |
| Omnicell (OMCL) | United States | $1.397B | 24.65 |
| Azenta (AZTA) | United States | $1.251B | 58.15 |
| 10x Genomics (TXG) | United States | $1.149B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.627B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.601B | 0.00 |
| Claritev (CTEV) | United States | $0.591B | 0.00 |
| Talkspace (TALK) | United States | $0.549B | 164.00 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.403B | 0.00 |
| TruBridge (TBRG) | United States | $0.358B | 793.67 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.128B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.090B | 3.42 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |